ACB $9.110 (0.55%)

ACNNF $0.278 (-3.61%)

AERO $1.490 (-2.3%)

AGEEF $0.564 (-0.86%)

ALEAF $1.220 (-2.67%)

AMMJ $0.420 (6.33%)

APHA $7.800 (-0.13%)

ARNA $45.920 (0.68%)

ATT:CNX $0.080 (0%)

ATTBF $0.047 (0.97%)

AUSA:CNX $1.080 (-3.57%)

AUSAF $0.800 (-5.1%)

AVXL $2.950 (0.68%)

BAMM:CNX $3.300 (-4.9%)

BBM:CNX $0.700 (1.45%)

BBRRF $0.520 (1.96%)

BE:CNX $0.105 (5%)

BIO:CNX $0.510 (-3.77%)

BLEVF $0.071 (-3.4%)

BLIS:CNX $0.490 (-1.01%)

BLO:CNX $1.390 (-0.71%)

BLOZF $1.045 (-0.48%)

BUDZ $0.920 (4.55%)

BXNG $0.490 (6.52%)

CADMF $1.530 (3.33%)

CALI:CNX $0.145 (-9.38%)

CANN $1.660 (7.1%)

CARA $19.040 (0.69%)

CBII:CNX $0.300 (0%)

CBWTF $0.663 (-0.3%)

CGC $48.370 (2.02%)

CGRW $0.608 (-2.33%)

CHOO:CNX $0.520 (0%)

CHOOF $0.397 (-0.45%)

CNAB $0.355 (-1.39%)

CNBX $0.335 (-1.38%)

CNGGF $1.783 (12.92%)

CODI $16.480 (0.86%)

CPMD $1.900 (0%)

CRBP $7.150 (-2.46%)

CRON $16.590 (1.9%)

CROP:CNX $0.300 (0%)

CRXPF $0.228 (-1.17%)

CSI:CNX $2.060 (1.48%)

CTST $7.560 (4.13%)

CURR $3.100 (0%)

CVSI $5.690 (0.71%)

CWEB:CNX $25.940 (-3.93%)

DIGP $0.181 (-2.16%)

DXBRF $0.876 (0.46%)

EAPH $0.010 (9.79%)

EAT:CNX $0.245 (-3.92%)

EEVVF $0.324 (1.41%)

EMHTF $2.950 (3.51%)

EPWCF $0.128 (0%)

EVIO $0.422 (-1.86%)

FFRMF $0.130 (1.17%)

FFT:CNX $0.180 (2.86%)

FNNZF $0.110 (-2.22%)

FSDDF $0.185 (-12.79%)

GGTTF $0.510 (4.93%)

GLDFF $0.110 (15.1%)

GLH:CNX $0.140 (7.69%)

GLNNF $0.117 (0.33%)

GNBT $1.200 (-1.64%)

GRIN:CNX $0.385 (2.67%)

GRWG $2.870 (-1.93%)

GTBIF $15.544 (-2.49%)

GTII:CNX $21.000 (-2.33%)

GWPH $161.030 (-2.74%)

HC:CNX $0.330 (-5.71%)

HEXO $7.130 (1.86%)

HHPHF $0.245 (-7.47%)

HLSPY $0.556 (-6.48%)

HMLSF $15.547 (0.3%)

HMPPF $0.750 (2.47%)

HRVOF $0.640 (-0.68%)

HSTRF $0.368 (0%)

HUGE:CNX $0.250 (-9.09%)

IAN:CNX $6.830 (-2.43%)

IGC $1.490 (-3.87%)

IGXT $0.540 (0.22%)

IIPR $84.230 (0.37%)

IMLFF $0.340 (-2.86%)

INQD $0.039 (15.57%)

INSY $4.310 (-3.36%)

IONC:CNX $0.820 (10.81%)

ISOL:CNX $1.270 (-2.31%)

ISOLF $0.942 (-2.83%)

ITHUF $5.080 (-2.12%)

IVITF $0.520 (-0.59%)

JWCAF $0.769 (1.6%)

KALTF $0.036 (-1.64%)

KBEV:CNX $0.465 (6.9%)

KBEVF $0.347 (5.17%)

KHRNF $2.279 (-2.61%)

KSHB $5.525 (-1.34%)

LDS:CNX $0.560 (-11.11%)

LDSYF $0.425 (-6.91%)

LHS:CNX $0.890 (-2.2%)

LHSIF $0.670 (-1.73%)

LIHT:CNX $0.220 (-2.22%)

LIHTF $0.165 (-2.94%)

LOVE:CNX $0.190 (0%)

LVWL:CNX $0.740 (0%)

LXLLF $0.990 (48.87%)

LXRP $1.018 (-4.01%)

LXX:CNX $1.360 (-2.86%)

MCIG $0.087 (16.89%)

MDCL $3.180 (6.35%)

MEDIF $4.180 (-7.32%)

MGWFF $0.120 (0%)

MICWF $0.269 (-3.63%)

MJ:CNX $0.450 (4.65%)

MJNA $0.060 (-1.16%)

MNTR $0.430 (0.12%)

MRRCF $0.685 (0.66%)

MWM:CNX $0.360 (-6.49%)

MYM:CNX $0.530 (0%)

MYMMF $0.390 (-1.86%)

NCNNF $0.701 (0.14%)

NDVAF $0.376 (-2.36%)

NGW:CNX $0.485 (-1.02%)

NRXCF $0.055 (0.74%)

NSPDF $0.090 (-1.26%)

NTEC $6.200 (-0.48%)

NVSIF $0.288 (-3.21%)

NVTQF $0.015 (-0.67%)

NWKRF $0.428 (2.71%)

NXGWF $0.358 (-2.71%)

NXTTF $0.540 (45.95%)

OGRMF $6.620 (-1.15%)

OH:CNX $12.430 (2.73%)

ORHOF $9.240 (2.44%)

OWCP $0.021 (-10.06%)

PHGI:CNX $0.690 (-1.43%)

PHGRF $0.501 (-3.86%)

PHVAF $0.678 (2.2%)

PILL:CNX $0.750 (-3.85%)

PKG:CNX $0.300 (3.45%)

PLPRF $3.550 (-5.69%)

PLUS:CNX $4.750 (-4.81%)

PMCB $0.042 (1.71%)

PNPL $0.520 (0%)

POTN $0.127 (-3.05%)

PRCNF $0.133 (10.58%)

PTNYF $0.223 (1.6%)

PUFXF $0.380 (-0.78%)

QCA:CNX $0.230 (-4.17%)

RDDTF $0.710 (-2.97%)

RLLVF $0.062 (-4.46%)

RQB:CNX $0.700 (0%)

RQHTF $0.197 (0%)

RVVQF $0.525 (2.74%)

SLNG:CNX $2.590 (-3%)

SMG $83.250 (-0.23%)

SNN:CNX $5.000 (1.01%)

SNNVF $3.720 (1.35%)

SOL:CNX $2.960 (0%)

SOLCF $2.210 (0%)

SPLIF $0.185 (-2.97%)

SPRWF $1.490 (0.68%)

SRNA $0.056 (0.22%)

STEM:CNX $2.520 (-1.18%)

STMH $1.900 (0%)

TBPMF $0.494 (-1.25%)

TCAN:CNX $7.430 (13.26%)

TDRYF $0.309 (0%)

TER:CNX $8.170 (-1.57%)

TGEN $3.970 (2.07%)

TGIF:CNX $0.470 (0%)

TGIFF $0.349 (1.1%)

THC:CNX $0.290 (3.57%)

THCBF $0.221 (6.59%)

TLRY $51.300 (2.07%)

TOKI:CNX $0.195 (8.33%)

TRLFF $0.325 (0.9%)

TRPX $3.400 (0%)

TRSSF $6.062 (-1.75%)

TRTC $0.851 (-3.3%)

TURV $0.460 (9.52%)

VBIO $0.460 (0%)

VIDA:CNX $0.920 (3.37%)

VIN:CNX $0.520 (0%)

VPRB $0.077 (-3.01%)

VRNDF $1.198 (2.37%)

VRT:CNX $0.540 (-1.82%)

VRTHF $0.400 (-4.53%)

VVCIF $0.670 (4.12%)

WAYL:CNX $0.920 (2.22%)

WDDMF $1.380 (-1.09%)

XXII $1.980 (3.13%)

ZDPY $0.356 (7.88%)

ZYNE $10.010 (1.11%)

Back

Blueberries Medical Appoints Former PharmaCielo CEO Dr. Patricio Stocker as Chief Executive Officer

Mar 20, 2019 • 11:57 AM GMT+0000
3 MIN READ  •  By Michael Berger
Share Share - Facebook Share - Twitter

BBM.CN) (BBRRF) (1OA.F) (the “Company” or “Blueberries”), a leading Colombia-based licensed producer of medicinal cannabis and cannabis-derived products is pleased to announce the appointment of Dr. Patricio Stocker, the former Chief Executive Officer of PharmaCielo Ltd. (PCLO.V) as Chief Executive Officer of the Company. Mr. Christian Toro has been appointed as Executive Chairman of the Board.

Dr. Stocker is an accomplished executive with extensive international experience having led the successful development of numerous companies, including most recently PharmaCielo Ltd. (“PharmaCielo”), a leading Colombian producer of medicinal cannabis. Dr. Stocker joined PharmaCielo in 2015 and served as CEO through 2018. During his tenure of as CEO, Dr. Stocker was instrumental in the development of corporate strategies, formation of strategic relationships, the cannablis licensing process and capital raising initiatives. Dr. Stocker was also actively involved in the development of PharmaCielo’s Colombian operations to establish a scalable and competitive cultivation and oil production strategy.

“Dr. Stocker has a proven track record of growing emerging businesses, combined with extensive expertise in the cannabis industry and capital markets. The board of directors is confident that his skillset and experience make him an ideal leader for the company as we continue to scale our operations rapidly and execute on our global growth strategy” stated Christian Toro, Executive Chairman.  

Dr. Stocker stated “I have been very impressed with Blueberries on a number of fronts. Their team, relationships, facilities and strategy are unique and have positioned the Company to become a dominant player in the Latin American and global cannabis markets. I am looking forward to leading Blueberries as we continue to execute on a domestic and international business plan.”

Dr. Stocker is fluent in English, Spanish, German and Portuguese. He also holds a PhD in Economics and B.A. in Business Administration from the University of St. Gallen in Switzerland. Prior to his role as CEO of PharmaCielo, Dr. Stocker held top management positions in the automotive industry, including service on the board of directors of multinational corporations.

The Company has granted 1,000,000 compensation shares to Dr. Stocker as well as options (the “Options”) to purchase up to 3,000,000 common shares in the capital of the Company, pursuant to the Company’s stock option plan. The Company has also granted 100,000 Options to advisors of the Company pursuant to the Company’s stock option plan. The Options are exercisable at a price of $0.55 per share.

Additional information about the Company is available at www.blueberriesmed.com. For more information, please contact:

angarita@pactarelations.com
Tel: +1 (305) 877 4710″ type=”text”>Jessika Angarita, Pacta Relations 
angarita@pactarelations.com 
Tel: +1 (305) 877 4710

Share Share - Facebook Share - Twitter

Tags

Authored By

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners, LLC and Founder of Technical420.com. Prior to entering the cannabis industry, Michael was an Equity Research Analyst at Raymond James Financial covering the Energy Sector. Michael has been featured in publications such as The Street, Bloomberg, US Money News, and hosts various cannabis events across North America.

Comments

Get the Latest Cannabis News & Stock Picks.

Enter your email below to join the official Technical420 newsletter.

 All good -- no spamming here.